Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

caregiving

Understanding COVID-19 and varying responses across the globe

At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global...

Blue Latitude Health

- PMLiVE

Moderna’s COVID-19 vaccine enters pivotal phase 3 trial

Large-scale study will evaluate vaccine in 30,000 participants

- PMLiVE

Pfizer, BioNTech identify and advance lead COVID-19 vaccine candidate

Companies pick the most promising candidate to take into phase 2/3

AstraZeneca AZ

Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

Follows initial deal agreed in June

Persuasive technology: designing behaviour change initiatives for digital

By Michelle Kelly

- PMLiVE

Origins Insights: views from the team

First in a video series from the Origins Insights team discussing some of our views, experiences, values and opinions across many aspects of qualitative patient research activities.

Resonant Group

When community can inspire a social media movement

Natalie Karaminas, Account Director, PR & Creative Communications at Havas Life Medicom, shares the value of social media in building online communities to spark a movement

Havas Life London

- PMLiVE

GSK’s anti-BCMA drug leads crowded CHMP recommendations

Ten new drugs receive positive recommendations for approval

- PMLiVE

Novartis’ Sandoz division announces antibiotic manufacturing plan

Joint investment agreed with the Austrian federal government

- PMLiVE

How to create real, lasting change after COVID-19

By David Thompson and Paul Tanner

- PMLiVE

New hires at EMA, Gilead and BeiGene

EMA gains a new executive director, Gilead appoints a new senior vice president and BeiGene hires a new chief business exec

- PMLiVE

Biogen plans Spinraza study in SMA patients treated with Novartis’ Zolgensma

Company aims to extend market reach

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links